高危患者DeBakey I型主动脉夹层的单阶段杂交修复术
回顾性分析120例DeBakey I型主动脉夹层患者接受零区全主动脉弓杂交修复术(升主动脉修复+全去分支+胸主动脉腔内修复)的结果,早期死亡率为9.2%,复合终点发生率为11.7%,中位随访3.4年总生存率为84.7%,5年免于晚期主动脉不良事件为93.1%。
要点
- 高危DeBakey I型夹层患者行零区杂交修复术,早期死亡率为9.2%(11/120)。
- 灌注不良综合征是早期复合终点的预测因素(OR 4.789,95%CI 1.362-16.896,p=.015)。
- 既往脑血管意外和心肌缺血时间预测短期和长期总死亡率。
核心结论
- 零区杂交修复术可安全、持久地治疗DeBakey I型主动脉夹层,尽管患者年龄较大且高危,围手术期死亡率和并发症发生率并未显著增高。
研究设计与样本
- 回顾性分析前瞻性收集的数据,纳入120例连续DeBakey I型主动脉夹层患者,平均EuroSCORE为11.6%,在7.5年期间接受零区杂交修复术(升主动脉重建+全弓去分支+胸主动脉腔内修复),其中97例(80.8%)为急诊/紧急手术。
- 对27项潜在术前和术中危险因素进行多变量分析,以评估早期复合终点及短期和长期总死亡率。
主要发现
- 早期(30天或住院期间)总死亡率为9.2%(n=11),复合终点发生率为11.7%(n=14)。
- 多变量分析显示,灌注不良综合征是复合终点的预测因素(OR 4.789,95%CI 1.362-16.896,p=.015),既往脑血管意外(OR 13.74,95%CI 2.330-81.039,p=.004)和心肌缺血时间(OR 1.038,95%CI 1.015-1.061,p=.001)预测短期和长期总死亡率。
- 中位随访3.4年期间总生存率为84.7%,5年免于晚期主动脉不良事件(包括二次主动脉干预和内漏)为93.1%。
- 支架段胸主动脉(14.4±6.5 mm增至29.7±5.3 mm,p<.001)、下胸主动脉(14.2±6 mm增至21.6±7.2 mm,p<.001)和腹主动脉(11.7±4.8 mm增至17.4±4.1 mm,p<.001)真腔最大直径显著增加。
- 术后平均12±17个月(中位5个月;25-75%四分位距2-12个月)的CT扫描中,88.2%(82/93)实现支架周围假腔完全血栓形成。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the efficacy of the less invasive hybrid zone 0 (Z0) total aortic arch repair (HAR, ascending repair + complete debranching + thoracic endovascular aortic repair [TEVAR]) without deep hypothermic circulatory arrest in management of DeBakey type I aortic dissection (IAD). The adverse outcome was defined as a single composite endpoint comprising peri-operative mortality, permanent neurological deficit, and renal failure necessitating haemodialysis at discharge. METHODS: A retrospective review of prospectively collected data was conducted of 120 consecutive patients (mean EuroSCORE = 11.6%) with IAD undergoing HAR (urgent/emergency, n = 97, 80.8%) involving reconstruction of the ascending aorta (zone 0) and total arch exclusion with TEVAR during a 7.5 year period. Multivariable analysis of 27 potential pre-operative and intra-operative risk factors was performed to examine the early composite endpoint and short and long-term overall mortality. RESULTS: The total early (30 day or in hospital) mortality was 9.2% (n = 11). The incidence of the composite endpoint was 11.7% (n = 14). On multivariable analysis, malperfusion syndromes were predictors of the composite endpoint (odds ratio [OR], 4.789; 95% CI 1.362-16.896; p = .015), and previous cerebrovascular accident (OR, 13.74; 95% CI 2.330-81.039; p = .004) and myocardial ischaemia time (OR, 1.038; 95% CI 1.015-1.061; p = .001) predicted short and long-term overall mortality. The overall survival was 84.7% during a median follow up of 3.4 years. Freedom from late aortic adverse events was 93.1% at 5 years, including secondary aortic intervention and endoleak. The maximum diameters of the true lumen increased significantly in stented thoracic (14.4 ± 6.5 mm to 29.7 ± 5.3 mm, p < .001), lower thoracic (14.2 ± 6 mm to 21.6 ± 7.2 mm, p < .001) and abdominal (11.7 ± 4.8 mm to 17.4 ± 4.1 mm, p < .001) aorta. Complete thrombosis of the peri-stent false lumen was achieved in 88.2% of CT scans (82/93) performed a mean of 12 ± 17 months (median 5 months; 25-75% quartile, 2-12 months) post-operatively. CONCLUSIONS: IAD was treated safely and durably by Z0 HAR, and peri-operative mortality and morbidity were not substantially higher despite the older age and high risk of patients.
引用
- Lin H, Du Y, Yu C, et al. Single Stage Hybrid Repair for DeBakey Type I Aortic Dissection in High Risk Patients. Eur J Vasc Endovasc Surg. 2018. PMID: 30077437. doi:10.1016/j.ejvs.2018.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。